Advertisement

Topics

FDA Approves First VTE Treatment for Pediatric Patients

20:00 EDT 16 May 2019 | BioSpace

Pfizer's Fragmin was approved to reduce the recurrence of VTE in patients one month of age or older.

Original Article: FDA Approves First VTE Treatment for Pediatric Patients

NEXT ARTICLE

More From BioPortfolio on "FDA Approves First VTE Treatment for Pediatric Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...